Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $54
Morgan Stanley analyst Vikram Purohit maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and raises the price target from $27 to $54.
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
